Infliximab and rate of ICU admission in COVID-19 patients:
The rate of ICU admission was not statistically significant between the
two groups according to our study.
Based on Gohda et. al., retrospective study, the ICU-admitted patients
with SARS-CoV-2 infection had significantly increased blood
concentrations of Tumor Necrosis Factor receptor 1 and 2 (TNFR1, 2)
rather than patients who did not hospitalize in ICU section after
adjustment the confounding factors [21].